Strumento inattivo

Altre lingue Antares Pharma, Inc.

Azioni

ATRS

US0366421065

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

ANTARES PHARMA, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Cha (form 8-K)	24/05/22
Antares Pharma, Inc. Announces Management Changes	24/05/22
Antares Pharma, Inc.(NasdaqCM:ATRS) dropped from NASDAQ Composite Index	24/05/22
Antares Pharma, Inc.(NasdaqCM:ATRS) dropped from S&P Pharmaceuticals Select Industry Index	24/05/22
Antares Pharma, Inc.(NasdaqCM:ATRS) dropped from S&P Global BMI Index	24/05/22
Antares Pharma, Inc.(NasdaqCM:ATRS) dropped from S&P TMI Index	24/05/22
Halozyme Therapeutics, Inc. completed the acquisition of Antares Pharma, Inc..	23/05/22
Halozyme Says Antitrust Act Waiting Period Expires for Antares Pharma Acquisition	12/05/22
ANTARES PHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	10/05/22
Antares Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS	05/05/22
Halozyme Therapeutics Launches Cash Tender Offer to Acquire Antares Pharma Shares	26/04/22
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS	26/04/22
Sector Update: Health Care Stocks Putting Up Modest Gains This Afternoon	13/04/22
Health Care Up Amid Deal Activity -- Health Care Roundup	13/04/22
Sector Update: Health Care Stocks Edging Higher Wednesday Afternoon	13/04/22
Top Midday Gainers	13/04/22
Halozyme to Acquire Antares Pharma for $960 Million; Antares Shares Surge	13/04/22
Antares Pharma : Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader - Form 8-K	13/04/22
ANTARES PHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	13/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Antares Pharma, Inc.

Azioni

ATRS

US0366421065

Altre lingue

Filtri